Key Details
The Health Ministry has proposed replacing the microbial-contamination limits table in Schedule M of the Drugs Rules, 1945, which sets manufacturing requirements for sterile products.
Where it applies: Grade A clean areas, where exposed sterile products, containers and components are handled.
Proposed limit: “No growth” for microbial monitoring in Grade A areas, in line with WHO guidance for sterile pharmaceutical manufacturing.
Regulatory status: This is a draft amendment, not a rule already in force. The government has invited objections and suggestions before finalising it.
The Tightest Clean-Area Standard Would Become Explicit
Grade A areas are the points in sterile manufacturing where contamination poses a particularly direct risk to a product. The proposed “no growth” limit means that detecting microbes through monitoring would prompt an investigation, rather than being treated as acceptable within a numerical threshold. The draft would bring the relevant Indian table into line with WHO’s standard.
The Change Concerns Manufacturing Controls, Not a New Product Test
The amendment addresses environmental monitoring inside manufacturing facilities. It does not, by itself, establish that medicines currently on the market are contaminated or change the requirements for every stage of drug production. Manufacturers of affected sterile products would need to assess their monitoring and investigation procedures against the final rule once issued.
Policy Relevance
For patients, the intended benefit is stronger prevention and detection of contamination in medicines that must remain sterile, such as injectables and sterile eye preparations. Whether the amendment improves protection will depend on consistent monitoring, prompt investigation of detected growth and effective regulatory inspection.
Relevant Question for Policy Stakeholders: How will regulators assess whether manufacturers investigate every detection of microbial growth in Grade A areas and address its cause?
Follow the Full Draft Notification Here: G.S.R. 953(E), Proposed Amendment to Schedule M · Health Ministry Press Release